Case Study: Adaptive Design in Duchenne Muscular Dystrophy
Case Study: Adaptive Design in Duchenne Muscular Dystrophy How Adaptive Trial Design Accelerated Drug Development in Duchenne Muscular Dystrophy Overview: The Urgency of Drug Development in DMD Duchenne Muscular Dystrophy (DMD) is a progressive, X-linked neuromuscular disorder affecting approximately 1 in 3,500–5,000 live male births globally. With no cure and limited treatment options, timely development…
Read More “Case Study: Adaptive Design in Duchenne Muscular Dystrophy” »